China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Using a Smart Medication Support System to Help Patients on New Dual-Target Immunotherapy Better Manage Treatment Side Effects'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132583
Registration Time: 2026/09/16
Type: Interventional study
Primary Sponsor: Fujian Cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333719
Published by HT Digital Content Services with permission from Health Daily Digest....